Glucose-sensitive insulin with attenuation of hypoglycaemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed.

1. ERAD-level gene switches for on-demand protein secretion and rapidly controlled gene therapies.Nature communications · 2026
   Article
2. Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment.Science advances · 2026
   Article
3. The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus.Diabetes, obesity & metabolism · 2026
   Review
4. Diabetic gastroparesis: pathophysiology and impact on insulin timing choices.Endocrine · 2026
   Review
5. Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of Hypoglycemia.ACS pharmacology & translational science · 2026
   Article
6. Free energy simulations on a biomimetic glucose receptor: understanding the selectivity of GluHUT.Chemical science · 2026
   Article
7. Toxicological profile of anti-diabetic drugs and emerging measures to reduce the toxic burden.Toxicology reports · 2026
   Review
8. pH and Glucose Dual-Responsive Hybrid Polymeric Smart Insulin Carrier for Diabetes Treatment.Polymers · 2026
   Article
9. Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification.Small science · 2026
   Article
10. [Advances in injectable and transdermal glucose-responsive insulin delivery systems].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
11. Nanomolar Affinity Host-Dye Reporter Pairs from Fluorescently Labeled Oligoarginine Peptides and p-Sulfonatocalix[4]arene.Chembiochem : a European journal of chemical biology · 2026
    Article
12. Material-driven glucose responsiveness in insulin delivery systems: carrier selection and performance.Frontiers in endocrinology · 2026
    Review
13. Hypoglycemia induces brain metabolic reprogramming and neurodegeneration via serum response factor and myocardin-related transcription factor-A.Signal transduction and targeted therapy · 2025
    Article
14. A pH-Responsive Synthetic Receptor for Switchable Binding of Carbohydrates.ChemPlusChem · 2025
    Article
15. Identification of SEC16B as a novel regulator of glucose homeostasis.Diabetologia · 2025
    Article
16. Smart closed-loop drug delivery systems.Nature reviews bioengineering · 2025
    Article
17. Advances in applied supramolecular technologies 2021-2025.Chemical Society reviews · 2025
    Review
18. A Synthetic Lectin for Glucuronate.ACS central science · 2025
    Article
19. Embracing Complexity: Peptides as Tunable Scaffolds in the Construction of Discrete Supramolecular Systems.Angewandte Chemie (International ed. in English) · 2025
    Review
20. Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems.Journal of diabetes science and technology · 2025
    Review

Corrections and comments

• Commented on by
  Glucose-sensitive insulin protects against hypoglycaemia.2024

Authors and funding

32 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as